Somatostatin Market North America: Regional Revenue, CAGR &...

σε πρόσθεσε στο άλλο

2026-10-29 14:13:20 -

Somatostatin Market North America: Regional Revenue, CAGR & Opportunities

North America leads the somatostatin market, with the US as the dominant contributor and Canada adding steady demand. Somatostatin analogs such as octreotide, lanreotide, and pasireotide are widely used for acromegaly, neuroendocrine tumors (NETs), carcinoid syndrome, and Cushing’s disease, supported by strong reimbursement, specialist access, and high diagnosis rates....

0 Σχόλια 0 Μοιράστηκε 20 Views 0 Προεπισκόπηση